Ethica Industri Farmasi

Name

Ethica Industri Farmasi

Legal name

PT. Ethica Industri Farmasi

Website

https://ethica.co.id

Company type

Private

Founded year

1946

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Sterile Injectable Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Sterile injectables manufacturing
• Small volume parenteral
• Ampoule production
• Injectable pharmaceuticals
• Sterile drug manufacturing

Headquarters

HQ city

Bekasi

HQ country

Indonesia

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Manufacture and sale of injection drugs for critical and chronic disease treatment. Products include ampoules and vials with various pharmaceutical formulations.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels1 record

Core offering

PT. Ethica Industri Farmasi manufactures and sells sterile injectable pharmaceutical products for hospitals in Indonesia and select international markets. Its core portfolio comprises 31 small-volume parenteral injection drugs in ampoule (1–20 mL) and vial (2–10 mL) formats, used to treat critical and chronic diseases. Manufacturing is conducted at a GMP-certified, aseptic-filled, terminal-sterilized sterile technology facility covering more than 52,000 m2 in the Jababeka Industrial Estate, Cikarang.

Product overview

PT. ETHICA Industri Farmasi is a pharmaceutical company that manufactures injection drugs for critical and chronic disease sufferers in Indonesia. The company operates as a single-product pharmaceutical manufacturer focused on sterile injectable medications, with production capabilities for small volume parenteral injections including ampoules (1-20 mL) and vials (2-10 mL). The product portfolio includes 31 named pharmaceutical injection products such as Atropine Sulfate, Amiodarone HCI, Dopamine HCI, Epinephrine, Ketamine variants, Midazolam variants, and Norepinephrine Bitartrate Monohydrate, among others. The company also markets oral drug products since 1997 in addition to its core injection products.

Differentiator

Problem solved

Functional benefit

Products and services

• Atropine Sulfate Injection Atropine Sulfate sterile injection in ampoule format, used in hospitals for critical and chronic disease treatment.
• Atracurium Besilate Injection Atracurium Besilate sterile ampoule injection for critical and chronic disease treatment in hospital settings.
• Ascorbic Acid Injection Ascorbic Acid sterile ampoule injection for critical and chronic disease treatment.
• Amiodarone HCl Injection Amiodarone HCl sterile injection for critical and chronic cardiovascular disease treatment.
• Aminophylline Injection Aminophylline sterile ampoule injection for critical and chronic disease treatment.
• Amikacin Sulfate Injection Amikacin Sulfate sterile ampoule injection (antibiotic) for critical and chronic disease treatment.
• Bupivacaine HCl Monohydrate Injection Bupivacaine HCl Monohydrate sterile injection for anesthesia in surgical and procedural settings.
• Calcium Gluconate Injection Calcium Gluconate sterile ampoule injection used in critical and chronic disease treatment.
• Dopamine HCl Injection Dopamine HCl sterile injection for critical care cardiovascular support in hospitals.
• Dobutamine HCl Injection Dobutamine HCl sterile injection for critical care cardiovascular support.
• Epinephrine Injection Epinephrine sterile ampoule injection for emergency and critical care use.
• Ephedrine HCl Injection Ephedrine HCl sterile ampoule injection for critical and chronic disease treatment.
• Furosemide Injection Furosemide sterile injection for critical and chronic disease treatment.
• Hyoscine N-Butylbromide Injection Hyoscine N-Butylbromide sterile ampoule injection used for critical and chronic disease treatment.
• Ketorolac Trometamol Injection Ketorolac Trometamol sterile injection (NSAID) for acute pain management in hospital settings.
• Ketamine HCl 100mg Injection Ketamine HCl 100mg sterile ampoule injection for anesthesia and analgesia in hospital settings.
• Ketamine HCl 50mg Injection Ketamine HCl 50mg sterile ampoule injection for anesthesia and analgesia in hospital settings.
• Lidocain Compositum Injection Lidocaine Compositum sterile injection for local anesthesia in clinical and surgical use.
• Midazolam HCl 5mg Injection Midazolam HCl 5mg/1mL sterile injection for sedation and critical care use.
• Midazolam HCl 1mg Injection Midazolam HCl 1mg/1mL sterile injection for sedation and critical care use.
• Metoclopramide HCl Monohydrate Injection Metoclopramide HCl Monohydrate sterile ampoule injection for gastrointestinal and critical care indications.
• Methylergometrine Maleate Injection Methylergometrine Maleate sterile ampoule injection used in obstetric care for postpartum hemorrhage management.
• Norepinephrine Bitartrate Monohydrate Injection Norepinephrine Bitartrate Monohydrate sterile ampoule injection for critical care hemodynamic support.
• Neostigmine Metilsulfate Injection Neostigmine Metilsulfate sterile injection used in anesthesia and critical care.
• Oxytocin Injection Oxytocin sterile ampoule injection used in obstetric care for labor induction and postpartum hemorrhage control.
• Ondansetron HCl Dihydrate Injection Ondansetron HCl Dihydrate sterile injection for antiemetic use in critical and chronic disease treatment.
• Phenytoin Sodium Injection Phenytoin Sodium sterile injection for seizure control in critical and chronic neurological disease treatment.
• Rocuronium Bromide Injection Rocuronium Bromide sterile ampoule injection for neuromuscular blockade in anesthesia.
• Ranitidine HCl Injection Ranitidine HCl sterile injection for gastrointestinal indications in hospital care.
• Tranexamic Acid Injection Tranexamic Acid sterile ampoule injection for antifibrinolytic therapy in surgical and critical care settings.
• Zoledronic Acid Monohydrate Injection Zoledronic Acid Monohydrate sterile injection for chronic disease treatment including bone metabolism disorders.
• Oral Drug Products Oral pharmaceutical drug products marketed by Ethica since 1997, complementing the company's core sterile injection portfolio.

Quantifiable outcome

• First pharmaceutical company in Indonesia to produce injection products

Named customers2 records

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• FK (Farma Klik)coreStrategic or Co-development PartnerJoint venture established in October 2013 with FK (Farma Klik) to start the Greenfield project for the JBK plant at the Jababeka Industrial Estate. This partnership marked a significant expansion milestone for the company.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• PT Kalbe Farma: Indonesia's largest pharmaceutical manufacturer with a broad generics and injectables portfolio distributed through hospitals and pharmacies; directly comparable as a domestic pharma serving the same hospital channel.
• PT Indofarma: Indonesian state-linked pharmaceutical company manufacturing generic injectables and oral drugs for government hospital tenders; directly competes for the same government hospital procurement channel.
• PT Sanbe Farma: Indonesian pharmaceutical manufacturer with a meaningful sterile injectables and hospital-channel business; closely comparable product mix and distribution model to Ethica.
• PT Dexa Medica: Indonesian pharma group producing branded generics including injectable forms for institutional buyers; comparable as a domestic competitor in the same therapeutic categories.
• PT Phapros: Indonesian pharma manufacturer of generics including injectable forms serving the public hospital channel; comparable scale and product overlap with Ethica's sterile injectable portfolio.

Emerging players

• Aurobindo Pharma: Indian generic manufacturer with a growing sterile injectables franchise expanding into emerging markets; emerging global player whose low-cost injectable generics increasingly compete for ASEAN hospital tenders.

Broad incumbents

• B. Braun Melsungen: Global incumbent in sterile injectables, IV solutions, and infusion therapy with manufacturing and distribution across Asia; broad incumbent in the same product category serving hospital customers.
• Fresenius Kabi: Global manufacturer of sterile injectable pharmaceuticals, IV drugs, and medical devices for hospitals; broad incumbent offering overlapping capabilities and competing for the same critical-care injectable categories.
• Pfizer (Hospira): Through its Hospira heritage, Pfizer operates one of the largest global sterile injectable manufacturing networks including products like atropine, epinephrine, and ketamine; broad incumbent in the same therapeutic injectables space.

Regional players

• Thai Meiji Pharmaceutical: Thailand-based sterile injectable manufacturer serving ASEAN hospital channels with Japanese GMP heritage; regional player operating in a market where Ethica has obtained FDA approval and is exporting.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/ethica-industri-farmasi-pt

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ethica Industri Farmasi